TB no barrier to anti-TNF treatment

WASHINGTON -- Patients being treated with tumor necrosis factor (TNF) inhibitors who develop tuberculosis (TB) may safely reinstitute their biologic before completing the lengthy TB treatment regimen, a small retrospective study suggested.